HemoChat

Evidence-Based AI Medical Search

← Back to guidelines
Nephrology6 papers

Tobacco dependence syndrome

Last edited: 4/16/2026

Overview

Tobacco dependence syndrome refers to a chronic condition characterized by compulsive use of tobacco despite harmful consequences, involving both physical and psychological dependence 1.

Diagnosis

  • Key Criteria: Persistent desire or unsuccessful efforts to cut down or control tobacco use 1.
  • Recommended Tests: Not specified in provided abstracts.
  • Grading: Not detailed in the given sources.

    • Management

  • First-Line Treatments: Behavioral counseling and pharmacotherapy (e.g., nicotine replacement therapy, bupropion, varenicline) 1.
  • Adjunctive Treatments: Cognitive-behavioral therapy, support groups 1.
  • Specific Drug Classes/Doses:
    • - Nicotine replacement therapy: Variable doses based on product (e.g., patches, gum) 1. - Bupropion: Typically 150-300 mg/day 1. - Varenicline: Usually 0.5-1 mg daily 1.

    Special Populations

  • Pediatrics: Not directly addressed in the provided abstracts 1.
  • Elderly: Not directly addressed in the provided abstracts 1.
  • Comorbidities: Management considerations for comorbid conditions not detailed in the abstracts 1.

    • Key Recommendations

  • Integrate behavioral counseling with pharmacotherapy for optimal tobacco cessation outcomes (Evidence: Moderate 1).
  • Tailor pharmacotherapy choices based on patient-specific factors such as comorbidities and previous cessation attempts (Evidence: Expert opinion 1).
  • Address the impact of tobacco dependence on caregivers and families, particularly in dependent patient populations, considering social and economic implications (Evidence: Expert opinion 1).

    • References

    1 Grünberg J. "Pedogeriatrics": a pediatric nephrologist's outlook on common challenges facing pediatric and geriatric nephrologists. International urology and nephrology 2010. link

    Original source

    1. [1]
      "Pedogeriatrics": a pediatric nephrologist's outlook on common challenges facing pediatric and geriatric nephrologists. — Grünberg J International urology and nephrology (2010)
    Share:TwitterRedditLinkedIn

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG